The 2020 HFSA Annual Scientific Meeting: CE bundle contains slides and recordings of scientific sessions held during the HFSA Virtual Annual Scientific Meeting 2020. Viewers may browse slides and listen to recordings to enhance their knowledge and learn the latest in heart failure care, treatment, research, etc. Continuing education credits are available for this product.

HFSA’s Annual Scientific Meeting is intended for physicians, nurses, nurse practitioners, pharmacists, scientists, and health care professionals who specialize or have an interest in heart failure.

Following this course, users will be able to:

• Describe the epidemiology of HF and implement strategies for the prevention of HF.
• Discuss the current scientific basis of HF from the perspectives of cardiovascular physiology, neurohormones, tissue factors, molecular biology, and genetics.
• Identify the findings of basic science research and current clinical trials and describe their implications for current and future HF therapy.
• Implement optimal guideline-based therapeutic options for HF, including pharmacologic agents, non-pharmacologic options, such as diet and exercise; and implantable devices.
• Manage comorbidities including hypertension, diabetes, depression, sleep apnea, and chemotherapy.
• Demonstrate awareness of psychosocial, economic, regulatory, and ethical issues in the treatment of patients with HF.
• Explain the patient, provider and system-related factors that contribute to racial and ethnic health disparities.
• Implement strategies for effective management of the patient with HF, incorporating the family, encouraging selfcare, and employing the team approach.
• Outline strategies for transitioning patients from impatient to outpatient care and for reducing hospital readmissions.
• Engage in performance measurement and other site-based research.

Co-Chairs

Javed Butler, MD, MPH, MBA

Sandra B. Dunbar, RN, PhD

Peter Liu, MD, FRCPC

J Herb Patterson, PharmD, FHFSA

Program Committee

Jeffrey Alexis, MD

Larry Allen, MD MS, FHFSA

Arvind Bhimaraj, MD

Horng Chen, MD

Julie Creaser, RN, MSN

Anita Deswal, MD, MPH, FHFSA

Robert Didomenico, PharmD

Katherine E. Di Palo, PharmD, BCACP, BCGP

Eiran Gorodeski, MD MPH

Justin Grodin, MD MPH

Doug Jennings, PharmD

Peggy Kirkwood, RN MSN

Liviu Klein, MD

Walter J. Koch, PhD

Alanna Morris, MD, MSc, FHFSA

Srinivas Murali, MD

Gurusher Panjrath, MD (MBBS)

Mariann R. Piano, PhD, RN, FAHA, FAAN

Bunny Pozehl, PhD , RN

Julie Rosenthal, MD

Douglas Sawyer, MD, PhD

Kristen Sethares, PhD, RN, CNE, FAHA

Palak Shah, MD MS, FHFSA

Marc Simon, MD

Amanda Vest, MD FHFSA (MBBS)

Joseph C. Wu, MD, PhD

In support of improving patient care, The Heart Failure Society of America is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Successful completion of this CME activity, which includes participation in the evaluation component and post-test with 75% passing score, enables the participant to earn up to 12.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.

CE Satellite Symposium

The Heart Failure Society of America acknowledges the following for providing an unrestricted educational grant to support this year’s Satellite Symposia.

Supported by independent educational grants from:

Akcea Therapeutics

Alnylam Pharmaceuticals

Amyloidosis Research Consortium

AstraZeneca

Boehringer- Ingelheim Pharmaceuticals, Inc./ Lilly USA, LLC

Eidos Therapeutics

Merck

Pfizer

Interactive Workshops

The Heart Failure Society of America acknowledges the following for providing an in-kind donation to support this year’s workshop:

Abbott

ActiCare

Medtronic

Eko Devices, Inc